Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2010
10/21/2010US20100266609 Antibody Molecules Which Bind IL-17A and IL-17F
10/21/2010US20100266608 treating a solid malignant proliferative disease or hematological proliferative disease by using inhibitor to human IL-17
10/21/2010US20100266607 Antibody therapy for use in the digestive tract
10/21/2010US20100266606 Antibody therapy for highly pathogenic avian influenza virus
10/21/2010US20100266605 Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect
10/21/2010US20100266604 Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
10/21/2010US20100266603 Monoclonal Antibody Specific to Ochratoxin A
10/21/2010US20100266602 Method for Diagnosing Rheumatoid Arthritis via Assaying Myofibroblast-Like Synoviocytes for Fibroblast Activation Protein
10/21/2010US20100266601 Antibodies that inhibit tslp activity
10/21/2010US20100266600 Methods of using il-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive t cells
10/21/2010US20100266599 Human receptor proteins; related reagents and methods
10/21/2010US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
10/21/2010US20100266597 Cytokine receptor zcytor17 multimers
10/21/2010US20100266596 Therapeutic antibody purification method and method of use
10/21/2010US20100266595 Treatment of insulin-resistant disorders
10/21/2010US20100266594 Il-9 in fibrotic and inflammatory disease
10/21/2010US20100266593 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
10/21/2010US20100266592 Therapeutic antennapedia-antibody molecules and methods of use thereof
10/21/2010US20100266591 Method of treating erythropoietin hyporesponsive anemias
10/21/2010US20100266590 Combination therapy
10/21/2010US20100266589 Adjuvant cancer therapy
10/21/2010US20100266588 Breast Cancer Susceptibility Gene GT198 and Uses Thereof
10/21/2010US20100266587 Compositions and Methods to Treat Acute Myelogenous Leukemia
10/21/2010US20100266586 Variable antibodies
10/21/2010US20100266585 Monoclonal Antibodies Specific to Hemagglutinin and Neuraminidase from Influenza Virus H5-Subtype or N1-Subtype and Uses Thereof
10/21/2010US20100266584 Antibodies against the ectodomain of erbb3 and uses thereof
10/21/2010US20100266583 Inhibition of il-17 production
10/21/2010US20100266582 Inhibition of il-17 production
10/21/2010US20100266581 Compositions and methods for modulating s-nitrosogluthione reductase
10/21/2010US20100266580 Translocation and mutant tnk1 kinase in human lymphoma
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266578 Treatment and diagnostic methods for hypersensitive disorders
10/21/2010US20100266577 Method of Cancer Treatment with Antagonists of FAS Inhibitors
10/21/2010US20100266576 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications
10/21/2010US20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING
10/21/2010US20100266574 Oligoribonucleotides and Methods of Use Thereof for Treatment of Fibrotic Conditions and Other Diseases
10/21/2010US20100266543 Linked dibenzimidazole antivirals
10/21/2010US20100266542 Receptor coupling agents and therapeutic uses thereof
10/21/2010US20100266541 Methods and agents for modulating an immune response
10/21/2010US20100266540 Drug class for the treatment of cancer
10/21/2010US20100266535 Compounds Having CRTH2 Antagonist Activity
10/21/2010US20100266534 Human Lymphocyte Vaccine Adjuvant
10/21/2010US20100266533 Death Domain Containing Receptors
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266530 FcRN ANTIBODIES AND USES THEREOF
10/21/2010US20100266505 Immunotherapy regimes dependent on apoe status
10/21/2010US20100266502 Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
10/21/2010US20100266499 Cytokine receptor zcytor17 multimers
10/21/2010US20100266498 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
10/21/2010US20100266497 Internalizing Anti-CD74 Antibodies and Methods of Use
10/21/2010US20100266496 Anti-CD74 Immunoconjugates and Methods of Use
10/21/2010US20100266495 Anti-Cancer Activity of an Anti-Thymidine Kinase Monoclonal Antibody
10/21/2010US20100266494 Treatment of cancer with novel anti-il13 monoclonal antibodies
10/21/2010US20100266491 System for targeted delivery of therapeutic agents
10/21/2010US20100266490 Metalloproteinase Binding Proteins
10/21/2010DE19953021B4 Verfahren und Einrichtung zum Erzeugen eines Mehrfarbendruckes Method and apparatus for generating a multi-color print
10/21/2010CA2759393A1 Targeted detection of dysplasia in barrett's esophagus with a novel fluorescence-labeled polypeptide
10/21/2010CA2759013A1 Combination immunotherapy compositions against cancer and methods
10/21/2010CA2758921A1 Meningococcal and pneumococcal conjugate vaccine and method of using same
10/21/2010CA2758751A1 Antibodies against prostate specific membrane antigen
10/21/2010CA2758585A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease
10/21/2010CA2758548A1 Compositions and methods to treat acute myelogenous leukemia
10/21/2010CA2758490A1 Compositions for immunising against staphylococcus aerus
10/21/2010CA2758449A1 Treatment of inflammatory diseases by inhibiting cold-inducible rna-binding protein (cirp)
10/21/2010CA2758327A1 Use of vectors expressing intracellular polynucleotide binding proteins as adjuvants
10/21/2010CA2758297A1 Compositions and methods for treating cancer
10/21/2010CA2758276A1 Macrocyclic lactone combination compositions, vaccines and methods for producing same
10/21/2010CA2758274A1 Engineered botulinum neurotoxin
10/21/2010CA2758136A1 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability
10/21/2010CA2757730A1 Combination therapy using an anti-egfr agent(s) and igf-1r specific inhibitors
10/21/2010CA2757382A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/21/2010CA2756973A1 Use of trifunctional bispecific antibodies for the treatment of tumors associated with cd133+/epcam+cancer stem cells
10/20/2010EP2241887A2 Diagnostics, drug screening and treatment for cancer
10/20/2010EP2241625A1 Proteinase K resistant surface protein of neisseria meningitidis
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241616A1 Immunity enhancing lactic acid bacteria
10/20/2010EP2241578A1 Anti-cldn6 antibody
10/20/2010EP2241577A1 Anti-CD37 antibodies
10/20/2010EP2241333A1 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof
10/20/2010EP2241332A1 Therapeutic agent for pruritus
10/20/2010EP2241330A1 Contraceptive methods and compositions related to proteasomal interference
10/20/2010EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
10/20/2010EP2241328A1 Interleukin-1 inhibitors in the treatment of diseases
10/20/2010EP2241309A2 Methods for encapsulation of proteins and adjuants in microspheres
10/20/2010EP2240770A1 Methods for detection of cyclosporin a
10/20/2010EP2240570A1 Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation
10/20/2010EP2240517A1 Fdf03 antibodies and uses thereof
10/20/2010EP2240516A1 Methods and agents for improving targeting of cd138 expressing tumor cells
10/20/2010EP2240515A1 Antigen-binding polypeptides against cartilage degeneration
10/20/2010EP2240203A1 Alpha 5 - beta 1 antibodies and their uses
10/20/2010EP2240202A2 Allergy vaccine composition for mucosal administration
10/20/2010EP2240200A2 Therapeutic myelin sheath derived antagonist peptide conjugates
10/20/2010EP2240199A1 Influenza b vaccines
10/20/2010EP1989224B1 Immunogenic peptides and methods of use
10/20/2010EP1951882B1 Nucleic acids encoding vaccines against the porcine reproductive and respiratory syndrome virus (prrsv)
10/20/2010EP1877549B1 Hiv vaccine
10/20/2010EP1687338B1 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses thereof
10/20/2010EP1608402B1 Improved vaccines
10/20/2010EP1418941B9 Inducted immune response against the feline immunodeficiency virus
10/20/2010EP1383513B1 Tumor therapy with sindbis virus-based vectors
1 ... 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 ... 1823